Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis.

Hdl Handle:
http://hdl.handle.net/10147/135682
Title:
Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis.
Authors:
Lahiff, C; Khiaron, O B; Nolan, N; Chadwick, G A
Affiliation:
Department of Medicine, St. Columcilles Hospital, Loughlinstown, Co. Dublin, Ireland. conorlahiff@yahoo.com
Citation:
Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis. 2007, 176 (4):309-11 Ir J Med Sci
Journal:
Irish journal of medical science
Issue Date:
Dec-2007
URI:
http://hdl.handle.net/10147/135682
DOI:
10.1007/s11845-007-0087-x
PubMed ID:
17906888
Additional Links:
http://www.springerlink.com/content/y5536j19825gv752/
Abstract:
Pneumocystis carinii pneumonia (PCP) is a rare form of pneumonia associated with immune-suppression. It is common in patients with AIDS and with a CD4 count of less than 200 cells/mm(3). We report a case of PCP secondary to immune-suppression in a 41-year-old man with psoriatic arthritis being treated with the immune-modulatory agent etanercept.; Diagnosis of PCP was made histologically using tissue obtained via transbronchial biopsy.; There was a good response to standard treatment with high-dose co-trimoxazole.; This report highlights a recognised but previously unreported complication of etanercept.
Item Type:
Article
Language:
en
MeSH:
Adult; Arthritis, Psoriatic; Biopsy, Needle; Follow-Up Studies; Humans; Immunoglobulin G; Immunohistochemistry; Immunosuppression; Immunosuppressive Agents; Male; Pneumonia, Pneumocystis; Receptors, Tumor Necrosis Factor; Risk Assessment; Severity of Illness Index; Treatment Outcome; Trimethoprim-Sulfamethoxazole Combination
ISSN:
1863-4362

Full metadata record

DC FieldValue Language
dc.contributor.authorLahiff, Cen
dc.contributor.authorKhiaron, O Ben
dc.contributor.authorNolan, Nen
dc.contributor.authorChadwick, G Aen
dc.date.accessioned2011-07-08T15:28:35Z-
dc.date.available2011-07-08T15:28:35Z-
dc.date.issued2007-12-
dc.identifier.citationPneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis. 2007, 176 (4):309-11 Ir J Med Scien
dc.identifier.issn1863-4362-
dc.identifier.pmid17906888-
dc.identifier.doi10.1007/s11845-007-0087-x-
dc.identifier.urihttp://hdl.handle.net/10147/135682-
dc.description.abstractPneumocystis carinii pneumonia (PCP) is a rare form of pneumonia associated with immune-suppression. It is common in patients with AIDS and with a CD4 count of less than 200 cells/mm(3). We report a case of PCP secondary to immune-suppression in a 41-year-old man with psoriatic arthritis being treated with the immune-modulatory agent etanercept.-
dc.description.abstractDiagnosis of PCP was made histologically using tissue obtained via transbronchial biopsy.-
dc.description.abstractThere was a good response to standard treatment with high-dose co-trimoxazole.-
dc.description.abstractThis report highlights a recognised but previously unreported complication of etanercept.-
dc.language.isoenen
dc.relation.urlhttp://www.springerlink.com/content/y5536j19825gv752/en
dc.subject.meshAdult-
dc.subject.meshArthritis, Psoriatic-
dc.subject.meshBiopsy, Needle-
dc.subject.meshFollow-Up Studies-
dc.subject.meshHumans-
dc.subject.meshImmunoglobulin G-
dc.subject.meshImmunohistochemistry-
dc.subject.meshImmunosuppression-
dc.subject.meshImmunosuppressive Agents-
dc.subject.meshMale-
dc.subject.meshPneumonia, Pneumocystis-
dc.subject.meshReceptors, Tumor Necrosis Factor-
dc.subject.meshRisk Assessment-
dc.subject.meshSeverity of Illness Index-
dc.subject.meshTreatment Outcome-
dc.subject.meshTrimethoprim-Sulfamethoxazole Combination-
dc.titlePneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medicine, St. Columcilles Hospital, Loughlinstown, Co. Dublin, Ireland. conorlahiff@yahoo.comen
dc.identifier.journalIrish journal of medical scienceen
dc.description.provinceLeinster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.